Cancer drug design and discovery:
Gespeichert in:
| Weitere Verfasser: | |
|---|---|
| Format: | Elektronisch E-Book |
| Sprache: | English |
| Veröffentlicht: |
New York
Academic Press
2008
|
| Ausgabe: | 1st ed |
| Schlagworte: | |
| Beschreibung: | Print version record |
| Beschreibung: | 1 online resource (xv, 473 pages, [27] pages of plates) illustrations (some color) |
| ISBN: | 9780080554952 0080554954 9780123694485 0123694485 |
Internformat
MARC
| LEADER | 00000nmm a2200000zc 4500 | ||
|---|---|---|---|
| 001 | BV045342908 | ||
| 003 | DE-604 | ||
| 005 | 00000000000000.0 | ||
| 007 | cr|uuu---uuuuu | ||
| 008 | 181206s2008 |||| o||u| ||||||eng d | ||
| 020 | |a 9780080554952 |9 978-0-08-055495-2 | ||
| 020 | |a 0080554954 |9 0-08-055495-4 | ||
| 020 | |a 9780123694485 |9 978-0-12-369448-5 | ||
| 020 | |a 0123694485 |9 0-12-369448-5 | ||
| 035 | |a (ZDB-4-ENC)ocn299152535 | ||
| 035 | |a (OCoLC)299152535 | ||
| 035 | |a (DE-599)BVBBV045342908 | ||
| 040 | |a DE-604 |b ger |e rda | ||
| 041 | 0 | |a eng | |
| 082 | 0 | |a 616.994061 |2 22 | |
| 245 | 1 | 0 | |a Cancer drug design and discovery |c edited by Stephen Neidle |
| 250 | |a 1st ed | ||
| 264 | 1 | |a New York |b Academic Press |c 2008 | |
| 300 | |a 1 online resource (xv, 473 pages, [27] pages of plates) |b illustrations (some color) | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b c |2 rdamedia | ||
| 338 | |b cr |2 rdacarrier | ||
| 500 | |a Print version record | ||
| 505 | 8 | |a The ultimate source of information on the design of new anticancer agents, emphasising small molecules, this newest work covers recent notable successes resulting from the human genome and cancer genomics projects. These advances have provided information on targets involved in specific cancers that are leading to effective medicines for at least some of the common solid tumours. Unique sections explain the basic underlying principles of cancer drug development and provide a practical introduction to modern methods of drug design. Appealing to a broad audience, this is an excellent reference for translational researchers interested in cancer biology and medicine as well as students in pharmacy, pharmacology, or medicinal and biological chemistry, and clinicians taking oncology options. * Covers both currently available drugs as well as those under development * Provides a clinical perspective on trials of new anticancer agents * Presents drug discovery examples through the use of case histories | |
| 650 | 7 | |a MEDICAL / Oncology |2 bisacsh | |
| 650 | 7 | |a HEALTH & FITNESS / Diseases / Cancer |2 bisacsh | |
| 650 | 7 | |a Antineoplastic agents / Design |2 fast | |
| 650 | 7 | |a Antineoplastic agents / Development |2 fast | |
| 650 | 7 | |a Cancer / Chemotherapy |2 fast | |
| 650 | 4 | |a Antineoplastic Agents | |
| 650 | 4 | |a Drug Design | |
| 650 | 4 | |a Neoplasms / drug therapy | |
| 650 | 4 | |a Antineoplastic Agents | |
| 650 | 4 | |a Drug Design | |
| 650 | 4 | |a Neoplasms / drug therapy | |
| 650 | 4 | |a Antineoplastic agents |x Development |a Antineoplastic agents |x Design |a Cancer |x Chemotherapy | |
| 650 | 0 | 7 | |a Krebsforschung |0 (DE-588)4165564-3 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Cytostatikum |0 (DE-588)4068347-3 |2 gnd |9 rswk-swf |
| 689 | 0 | 0 | |a Krebsforschung |0 (DE-588)4165564-3 |D s |
| 689 | 0 | 1 | |a Cytostatikum |0 (DE-588)4068347-3 |D s |
| 689 | 0 | |8 1\p |5 DE-604 | |
| 700 | 1 | |a Neidle, Stephen |4 edt | |
| 776 | 0 | 8 | |i Erscheint auch als |n Druck-Ausgabe |t Cancer drug design and discovery |b 1st ed |d New York : Academic Press, 2008 |z 9780123694485 |z 0123694485 |
| 912 | |a ZDB-4-ENC | ||
| 999 | |a oai:aleph.bib-bvb.de:BVB01-030729611 | ||
| 883 | 1 | |8 1\p |a cgwrk |d 20201028 |q DE-101 |u https://d-nb.info/provenance/plan#cgwrk | |
Datensatz im Suchindex
| _version_ | 1804179161127845888 |
|---|---|
| any_adam_object | |
| author2 | Neidle, Stephen |
| author2_role | edt |
| author2_variant | s n sn |
| author_facet | Neidle, Stephen |
| building | Verbundindex |
| bvnumber | BV045342908 |
| collection | ZDB-4-ENC |
| contents | The ultimate source of information on the design of new anticancer agents, emphasising small molecules, this newest work covers recent notable successes resulting from the human genome and cancer genomics projects. These advances have provided information on targets involved in specific cancers that are leading to effective medicines for at least some of the common solid tumours. Unique sections explain the basic underlying principles of cancer drug development and provide a practical introduction to modern methods of drug design. Appealing to a broad audience, this is an excellent reference for translational researchers interested in cancer biology and medicine as well as students in pharmacy, pharmacology, or medicinal and biological chemistry, and clinicians taking oncology options. * Covers both currently available drugs as well as those under development * Provides a clinical perspective on trials of new anticancer agents * Presents drug discovery examples through the use of case histories |
| ctrlnum | (ZDB-4-ENC)ocn299152535 (OCoLC)299152535 (DE-599)BVBBV045342908 |
| dewey-full | 616.994061 |
| dewey-hundreds | 600 - Technology (Applied sciences) |
| dewey-ones | 616 - Diseases |
| dewey-raw | 616.994061 |
| dewey-search | 616.994061 |
| dewey-sort | 3616.994061 |
| dewey-tens | 610 - Medicine and health |
| discipline | Medizin |
| edition | 1st ed |
| format | Electronic eBook |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>03148nmm a2200577zc 4500</leader><controlfield tag="001">BV045342908</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">00000000000000.0</controlfield><controlfield tag="007">cr|uuu---uuuuu</controlfield><controlfield tag="008">181206s2008 |||| o||u| ||||||eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9780080554952</subfield><subfield code="9">978-0-08-055495-2</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">0080554954</subfield><subfield code="9">0-08-055495-4</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9780123694485</subfield><subfield code="9">978-0-12-369448-5</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">0123694485</subfield><subfield code="9">0-12-369448-5</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ZDB-4-ENC)ocn299152535</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)299152535</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV045342908</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rda</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">616.994061</subfield><subfield code="2">22</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Cancer drug design and discovery</subfield><subfield code="c">edited by Stephen Neidle</subfield></datafield><datafield tag="250" ind1=" " ind2=" "><subfield code="a">1st ed</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">New York</subfield><subfield code="b">Academic Press</subfield><subfield code="c">2008</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 online resource (xv, 473 pages, [27] pages of plates)</subfield><subfield code="b">illustrations (some color)</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Print version record</subfield></datafield><datafield tag="505" ind1="8" ind2=" "><subfield code="a">The ultimate source of information on the design of new anticancer agents, emphasising small molecules, this newest work covers recent notable successes resulting from the human genome and cancer genomics projects. These advances have provided information on targets involved in specific cancers that are leading to effective medicines for at least some of the common solid tumours. Unique sections explain the basic underlying principles of cancer drug development and provide a practical introduction to modern methods of drug design. Appealing to a broad audience, this is an excellent reference for translational researchers interested in cancer biology and medicine as well as students in pharmacy, pharmacology, or medicinal and biological chemistry, and clinicians taking oncology options. * Covers both currently available drugs as well as those under development * Provides a clinical perspective on trials of new anticancer agents * Presents drug discovery examples through the use of case histories</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">MEDICAL / Oncology</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">HEALTH & FITNESS / Diseases / Cancer</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Antineoplastic agents / Design</subfield><subfield code="2">fast</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Antineoplastic agents / Development</subfield><subfield code="2">fast</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Cancer / Chemotherapy</subfield><subfield code="2">fast</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Antineoplastic Agents</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drug Design</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Neoplasms / drug therapy</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Antineoplastic Agents</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drug Design</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Neoplasms / drug therapy</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Antineoplastic agents</subfield><subfield code="x">Development</subfield><subfield code="a">Antineoplastic agents</subfield><subfield code="x">Design</subfield><subfield code="a">Cancer</subfield><subfield code="x">Chemotherapy</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Krebsforschung</subfield><subfield code="0">(DE-588)4165564-3</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Cytostatikum</subfield><subfield code="0">(DE-588)4068347-3</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Krebsforschung</subfield><subfield code="0">(DE-588)4165564-3</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Cytostatikum</subfield><subfield code="0">(DE-588)4068347-3</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="8">1\p</subfield><subfield code="5">DE-604</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Neidle, Stephen</subfield><subfield code="4">edt</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Druck-Ausgabe</subfield><subfield code="t">Cancer drug design and discovery</subfield><subfield code="b">1st ed</subfield><subfield code="d">New York : Academic Press, 2008</subfield><subfield code="z">9780123694485</subfield><subfield code="z">0123694485</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-4-ENC</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-030729611</subfield></datafield><datafield tag="883" ind1="1" ind2=" "><subfield code="8">1\p</subfield><subfield code="a">cgwrk</subfield><subfield code="d">20201028</subfield><subfield code="q">DE-101</subfield><subfield code="u">https://d-nb.info/provenance/plan#cgwrk</subfield></datafield></record></collection> |
| id | DE-604.BV045342908 |
| illustrated | Illustrated |
| indexdate | 2024-07-10T08:15:28Z |
| institution | BVB |
| isbn | 9780080554952 0080554954 9780123694485 0123694485 |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-030729611 |
| oclc_num | 299152535 |
| open_access_boolean | |
| physical | 1 online resource (xv, 473 pages, [27] pages of plates) illustrations (some color) |
| psigel | ZDB-4-ENC |
| publishDate | 2008 |
| publishDateSearch | 2008 |
| publishDateSort | 2008 |
| publisher | Academic Press |
| record_format | marc |
| spelling | Cancer drug design and discovery edited by Stephen Neidle 1st ed New York Academic Press 2008 1 online resource (xv, 473 pages, [27] pages of plates) illustrations (some color) txt rdacontent c rdamedia cr rdacarrier Print version record The ultimate source of information on the design of new anticancer agents, emphasising small molecules, this newest work covers recent notable successes resulting from the human genome and cancer genomics projects. These advances have provided information on targets involved in specific cancers that are leading to effective medicines for at least some of the common solid tumours. Unique sections explain the basic underlying principles of cancer drug development and provide a practical introduction to modern methods of drug design. Appealing to a broad audience, this is an excellent reference for translational researchers interested in cancer biology and medicine as well as students in pharmacy, pharmacology, or medicinal and biological chemistry, and clinicians taking oncology options. * Covers both currently available drugs as well as those under development * Provides a clinical perspective on trials of new anticancer agents * Presents drug discovery examples through the use of case histories MEDICAL / Oncology bisacsh HEALTH & FITNESS / Diseases / Cancer bisacsh Antineoplastic agents / Design fast Antineoplastic agents / Development fast Cancer / Chemotherapy fast Antineoplastic Agents Drug Design Neoplasms / drug therapy Antineoplastic agents Development Antineoplastic agents Design Cancer Chemotherapy Krebsforschung (DE-588)4165564-3 gnd rswk-swf Cytostatikum (DE-588)4068347-3 gnd rswk-swf Krebsforschung (DE-588)4165564-3 s Cytostatikum (DE-588)4068347-3 s 1\p DE-604 Neidle, Stephen edt Erscheint auch als Druck-Ausgabe Cancer drug design and discovery 1st ed New York : Academic Press, 2008 9780123694485 0123694485 1\p cgwrk 20201028 DE-101 https://d-nb.info/provenance/plan#cgwrk |
| spellingShingle | Cancer drug design and discovery The ultimate source of information on the design of new anticancer agents, emphasising small molecules, this newest work covers recent notable successes resulting from the human genome and cancer genomics projects. These advances have provided information on targets involved in specific cancers that are leading to effective medicines for at least some of the common solid tumours. Unique sections explain the basic underlying principles of cancer drug development and provide a practical introduction to modern methods of drug design. Appealing to a broad audience, this is an excellent reference for translational researchers interested in cancer biology and medicine as well as students in pharmacy, pharmacology, or medicinal and biological chemistry, and clinicians taking oncology options. * Covers both currently available drugs as well as those under development * Provides a clinical perspective on trials of new anticancer agents * Presents drug discovery examples through the use of case histories MEDICAL / Oncology bisacsh HEALTH & FITNESS / Diseases / Cancer bisacsh Antineoplastic agents / Design fast Antineoplastic agents / Development fast Cancer / Chemotherapy fast Antineoplastic Agents Drug Design Neoplasms / drug therapy Antineoplastic agents Development Antineoplastic agents Design Cancer Chemotherapy Krebsforschung (DE-588)4165564-3 gnd Cytostatikum (DE-588)4068347-3 gnd |
| subject_GND | (DE-588)4165564-3 (DE-588)4068347-3 |
| title | Cancer drug design and discovery |
| title_auth | Cancer drug design and discovery |
| title_exact_search | Cancer drug design and discovery |
| title_full | Cancer drug design and discovery edited by Stephen Neidle |
| title_fullStr | Cancer drug design and discovery edited by Stephen Neidle |
| title_full_unstemmed | Cancer drug design and discovery edited by Stephen Neidle |
| title_short | Cancer drug design and discovery |
| title_sort | cancer drug design and discovery |
| topic | MEDICAL / Oncology bisacsh HEALTH & FITNESS / Diseases / Cancer bisacsh Antineoplastic agents / Design fast Antineoplastic agents / Development fast Cancer / Chemotherapy fast Antineoplastic Agents Drug Design Neoplasms / drug therapy Antineoplastic agents Development Antineoplastic agents Design Cancer Chemotherapy Krebsforschung (DE-588)4165564-3 gnd Cytostatikum (DE-588)4068347-3 gnd |
| topic_facet | MEDICAL / Oncology HEALTH & FITNESS / Diseases / Cancer Antineoplastic agents / Design Antineoplastic agents / Development Cancer / Chemotherapy Antineoplastic Agents Drug Design Neoplasms / drug therapy Antineoplastic agents Development Antineoplastic agents Design Cancer Chemotherapy Krebsforschung Cytostatikum |
| work_keys_str_mv | AT neidlestephen cancerdrugdesignanddiscovery |